Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. John M. Leonard, M.D.$2B
Market Cap • 24/04/20242014
(há 10 anos)
2016
(8 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts598
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NTLASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.